These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32171455)

  • 1. Erratum to: Trifiletti DM, Ballman KV, Brown PD, Anderson SK, Carrero XW, Cerhan JH, Whitton AC, Greenspoon J, Parney IF, Laack NN, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG II, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D. Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3). Int J Radiat Oncol Biol Phys 2020;106:255-260.
    Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):1111. PubMed ID: 32171455
    [No Abstract]   [Full Text] [Related]  

  • 2. Erratum to: Jones, CU; Pugh, SL; Sandler, HM; Chetner, MP; Amin, MB; Bruner, DW; Zietman, AL; Den, RB; Leibenhaut, MH; Longo, JM; Bahary, JP; Rosenthal, SA; Souhami, L; Michalski, JM; Hartford, AC; Amin, PP; Roach, M 3rd; Yee, D; Efstathiou, JA; Rodgers, JP; Feng, FY; Shipley, WU. Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial. Int J Radiat Oncol Biol Phys 2022;112:294-303. doi: 10.1016/j.ijrobp.2021.08.031.
    Int J Radiat Oncol Biol Phys; 2023 Jan; 115(1):265. PubMed ID: 36526397
    [No Abstract]   [Full Text] [Related]  

  • 3. Erratum to: Lee AW, Ng WT, Pan JJ, et al. International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys 2019;105:567-580.
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1166-1167. PubMed ID: 31748141
    [No Abstract]   [Full Text] [Related]  

  • 4. Erratum to: Wilkins AC, Gusterson B, Szijgyarto Z, et al. Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer. Int J Radiat Oncol Biol Phys 2018;101:309-315.
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):226. PubMed ID: 30967236
    [No Abstract]   [Full Text] [Related]  

  • 5. Erratum to: Caudell JJ, Torres-Saavedra PA, Rosenthal DI, Axelrod RS, et al. Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer. Int J Radiat Oncol Biol Phys 2023;116:533-543.
    Int J Radiat Oncol Biol Phys; 2023 Nov; 117(3):774-776. PubMed ID: 37578414
    [No Abstract]   [Full Text] [Related]  

  • 6. Erratum to: Pollack A, Chinea FM, Bossart E, Kwon D, Abramowitz MC, Lynne C, Jorda M, Marples B, Patel VN, Wu XD, Reis I, Studenski MT, Casillas J, Stoyanova R. Phase I Trial of MRI-Guided Prostate Cancer Lattice Extreme Ablative Dose (LEAD) Boost Radiation Therapy. Int J Radiat Oncol Biol Phys 2020;107:305-315.
    Int J Radiat Oncol Biol Phys; 2020 Sep; 108(1):328. PubMed ID: 32819616
    [No Abstract]   [Full Text] [Related]  

  • 7. Erratum to: Reddy J, Lei X, Bloom S, et al. Optimizing Preventive Adjuvant Linac-Based (OPAL) Radiation: A Phase 2 Trial of Daily Partial Breast Irradiation. Int J Radiat Oncol Biol Phys 2024;115(3): 629-644.
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):1034. PubMed ID: 38851265
    [No Abstract]   [Full Text] [Related]  

  • 8. Erratum to: Wallner PE, Anscher MS, Barker CA, et al. Current status and recommendations for the future of research, teaching, and testing in the biological sciences of radiation oncology: report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, executive summary. Int J Radiat Oncol Biol Phys 2014;88:11-17.
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1115. PubMed ID: 25832710
    [No Abstract]   [Full Text] [Related]  

  • 9. Erratum to: Jeans EB, Brower JV, Burmeister JW, Deville C, Fields E, Kavanagh BD, Suh JH, Tekian A, Vapiwala N, Zeman EM, Golden DW. Development of a United States Radiation Oncology Curricular Framework: A Stakeholder Delphi Consensus. Int J Radiat Oncol Biol Phys 2023;115:1030-1040.
    Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):868. PubMed ID: 38340774
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to "Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation" (Int J Radiat Oncol Biol Phys 2010;76:71-78) and "Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation" Int J Radiat Oncol Biol Phys 2009;75:1290-1296).
    Wolmark N; Curran WJ; Vicini F; White J; Costantino JP; Arthur D; Kuske R; Rabinovitch R; Julian TB; Parda DS
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):317; author reply 318. PubMed ID: 20394863
    [No Abstract]   [Full Text] [Related]  

  • 11. Erratum to: Park J, Venkatesulu BP, Kujundzic K, Katsoulakis E, Solanki AA, Puckett LL, Kapoor R, Chapman CH, Hagan M, Kelly MD, Palta J, Ashman JB, Jacqmin D, Kachnic LA, Minsky BD, Olsen J, Raldow AC, Wo JY, Dawes S, Wilson E, Kudner R, Das P. Consensus Quality Measures and Dose Constraints for Rectal Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology (ASTRO) Expert Panel. Pract Radiat Oncol 2022;12:424-436.
    Pract Radiat Oncol; 2023; 13(4):370-375. PubMed ID: 37391240
    [No Abstract]   [Full Text] [Related]  

  • 12. Lung V20 measurements: In regard to Seppenwoolde et al. (Int J Radiat Oncol Biol Phys 2003;55:724-735), and Tsujino et al. (Int J Radiat Oncol Biol Phys 2003;56:1208-1209).
    Garces YI; Miller RC
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1636; author reply 1636-7. PubMed ID: 15050346
    [No Abstract]   [Full Text] [Related]  

  • 13. Erratum to: Pignol J-P, Vu TTT, Mitera G, et al. Prospective Evaluation of Severe Skin Toxicity and Pain During Postmastectomy Radiation Therapy. Int J Radiat Oncol Biol Phys 2015;91:157-164.
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):702. PubMed ID: 26068501
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to "Stereotactic ablative radiotherapy in the framework of classical radiobiology: response to Drs. Brown, Diehn, and Loo." (Int J Radiat Oncol Biol Phys 2011;79:1599-1600) and "Influence of tumor hypoxia on stereotactic ablative radiotherapy (SABR): response to Drs. Mayer and Timmerman." (Int J Radiation Oncol Biol Phys 2011;78:1600).
    Song CW; Levitt SH; Park H
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1193; author reply 1193-4. PubMed ID: 22036162
    [No Abstract]   [Full Text] [Related]  

  • 15. Erratum to: Randomized, Double-Blinded, Placebo-controlled Multicenter Adaptive Phase 1-2 Trial of GC 4419, a Dismutase Mimetic, in Combination with High Dose Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (PC)  Int J Radiat Oncol Biol Phys 2020;108:1399-1400.
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):698. PubMed ID: 37270256
    [No Abstract]   [Full Text] [Related]  

  • 16. Erratum to: Hindley A, Zain Z, Wood L, et al. Mometasone furoate cream reduces acute radiation dermatitis in patients receiving breast radiation therapy: results of a randomized trial. Int J Radiat Oncol Biol Phys 2014;90:748-755.
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):882. PubMed ID: 25752410
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiotherapy in pleural malignant mesothelioma: why not! In regard to Scorsetti et al. (Int J Radiat Oncol Biol Phys 2010;77:942-949); Krayenbuehl et al. (Int J Radiat Oncol Biol Phys 2010;78:628-634).
    Russi EG; Numico G; Ricardi U
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1279; author reply 1279-80. PubMed ID: 21353165
    [No Abstract]   [Full Text] [Related]  

  • 18. Erratum to: Melidis C, Bosch WR, Izewska J, et al. Global harmonization of quality assurance naming conventions in radiation therapy Clinical Trials. Int J Radiat Oncol Biol Phys 2014;90:1242-1249.
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1115. PubMed ID: 25832708
    [No Abstract]   [Full Text] [Related]  

  • 19. Erratum to: Hypofractionated Radiation Therapy Combined With Weekly Chemotherapy in Patients With Unresectable or Recurrent Thymic Epithelial Tumor: A Prospective, Single-Arm Phase 2 Study (GASTO-1042). Int J Radiat Oncol Biol Phys. 2022 Sep 1;114(1):89-98.
    Chu Chu ; Liang Y; Lin X; Liu Y; Liu S; Guo J; Wang D; Wang J; Liu H; Qiu B
    Int J Radiat Oncol Biol Phys; 2023 Mar; 115(4):1014. PubMed ID: 36822779
    [No Abstract]   [Full Text] [Related]  

  • 20. Toward a unified survival curve: in regard to Kavanagh and Newman (Int J Radiat Oncol Biol Phys 2008;71:958-959) and Park et al. (IntJ Radiat Oncol Biol Phys 2008;70:847-852).
    McKenna F; Ahmad S
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):640; author reply 640-1. PubMed ID: 19147035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.